PD173074 3295668 Genetic and pharmacological disruption of

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

Chemical Name: (E)-N-(2-amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide

Arch Gynecol Obstet

61 583 PMID: 28692295

PD173074 3295668 Genetic and pharmacological disruption ofPD173074 is a small molecule FGFR3 selective tyrosine kinase inhibitor (TKI), as a therapeutic modality using eight UC cell lines. PD173074 suppressed cell proliferation remarkably in two cell lines, namely, UM UC 14 and MGHU3, which expressed mutated FGFR3 protein. Cell cycle analysis revealed the growth inhibitory effect of PD173074 was associated with arrest at G(1) S transition in a dose depending manner. In the mouse xenograft models using